Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHTCF.L Regulatory News (HTCF)

  • There is currently no data for HTCF

Succession Planning Update

16 Jul 2015 17:20

RNS Number : 3057T
BlueCrest AllBlue Fund Ltd
16 July 2015
 



16 July 2015

 

BLUECREST ALLBLUE FUND LIMITED (THE 'COMPANY')

 

SUCCESSION PLANNING UPDATE

 

In the Annual Financial Report for the year ended 31 December 2014 (the "AFR"), the Company advised that it was scheduled to consider the tenure of directors once any director has been appointed to the Board for a continuous period of nine years and that this would occur in 2015 for Messrs Crowder, Meader and Le Prevost, with the intention that in order to achieve orderly succession and to retain 'corporate memory', it is the intention of the Board that one of each of the above three directors should step aside in each calendar year starting in 2015. Notwithstanding their nine years service the Company considers that Richard, Paul and John remain able to act independently.

 

Further to this disclosure, investors may have noted that the Company has appointed Miss Sarita Keen as an independent non executive director effective 3 June 2015. Sarita brings an in depth knowledge of Guernsey fund administration and has already made a valuable contribution to the Board.

 

In line with the succession plan disclosed in the AFR it is the intention of the Company that Sarita takes on the duties of John Le Prevost in due course and that John Le Prevost will be the first of the three directors named above to retire. The Company anticipates that this will occur before the end of the year.

 

The Board believes that one of the distinctions of an investment company such as BCAB is that there are no executives or investment managers to carry out duties such as monitoring the valuation process, cash pot policy and conversion mechanism. For the Company the failure of any of these mechanisms is a significant risk and many of these procedures (for instance inter share class conversions) take place over a period of some 6-8 weeks, and so the Board considers that a 5 month handover period is not excessively long. However, five months is the anticipated maximum in this case.

 

The Board is also actively seeking a replacement for Richard Crowder, as chairman. Next year the Board will review the position of Paul Meader, in line with the succession plan.

 

For further information about this announcement contact:

 

JTC (Guernsey) Limited

Secretary

Tel: +44 (0) 1481 702 400

E&OE - in transmission

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRQQLFFEDFBBBK
Date   Source Headline
23rd Apr 201812:11 pmRNSEstimated Creditors Interest
23rd Apr 201811:52 amRNSNet Asset Value(s)
20th Apr 20182:00 pmRNSAppointment of Director
18th Apr 201811:34 amRNSNet Asset Value(s)
12th Apr 20184:51 pmRNSHolding(s) in Company
11th Apr 20185:42 pmRNSTransaction in Own Shares
10th Apr 20181:24 pmRNSNet Asset Value(s)
5th Apr 201810:15 amRNSNet Asset Value(s)
4th Apr 20186:32 pmRNSAnnual Financial Report
3rd Apr 20184:22 pmRNSHolding(s) in Company
29th Mar 20183:56 pmRNSHolding(s) in Company
28th Mar 201812:28 pmRNSEstimated Creditors Interest
28th Mar 201812:22 pmRNSNet Asset Value(s)
27th Mar 20185:39 pmRNSTransaction in Own Shares
27th Mar 20181:32 pmRNSNet Asset Value(s)
23rd Mar 20181:45 pmRNSHolding(s) in Company
21st Mar 20185:05 pmRNSTransaction in Own Shares
20th Mar 20185:25 pmRNSTransaction in Own Shares
20th Mar 20189:55 amRNSNet Asset Value(s)
16th Mar 20185:09 pmRNSTransaction in Own Shares
13th Mar 201810:04 amRNSNet Asset Value(s)
5th Mar 20189:50 amRNSNet Asset Value(s)
27th Feb 201811:30 amRNSNet Asset Value(s)
21st Feb 201811:14 amRNSNet Asset Value(s)
13th Feb 20189:07 amRNSNet Asset Value(s)
5th Feb 20189:41 amRNSNet Asset Value(s)
30th Jan 20189:51 amRNSNet Asset Value(s)
23rd Jan 20189:33 amRNSNet Asset Value(s)
17th Jan 201810:17 amRNSNet Asset Value(s)
10th Jan 20189:59 amRNSNet Asset Value(s)
4th Jan 201810:30 amRNSNet Asset Value(s)
28th Dec 20179:46 amRNSNet Asset Value(s)
21st Dec 20172:26 pmRNSInvestor Communication from AllBlue Limited
20th Dec 20175:52 pmRNSDirector's Other Directorship
19th Dec 20179:32 amRNSNet Asset Value(s)
15th Dec 20174:43 pmRNSHolding(s) in Company
12th Dec 201710:49 amRNSNet Asset Value(s)
5th Dec 20179:22 amRNSNet Asset Value(s)
28th Nov 201710:23 amRNSNet Asset Value(s)
22nd Nov 20179:29 amRNSEstimated Creditors Interest
22nd Nov 20179:27 amRNSNet Asset Value(s)
21st Nov 20179:48 amRNSNet Asset Value(s)
16th Nov 20179:18 amRNSNet Asset Value(s)
16th Nov 20179:16 amRNSEstimated Creditors Interest
14th Nov 20179:29 amRNSNet Asset Value(s)
7th Nov 20179:58 amRNSNet Asset Value(s)
31st Oct 20179:08 amRNSNet Asset Value(s)
24th Oct 201710:10 amRNSNet Asset Value(s)
17th Oct 20175:19 pmRNSHolding(s) in Company
17th Oct 201711:16 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.